查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594055

男性健康診斷市場：按產品類型、適應症、最終用戶分類 - 全球預測 2025-2030 年

Mens Health Diagnostics Market by Product (Blood Test, Electrocardiogram, MRI of the Prostate), Type or Indication (Colorectal Cancer, Erectile Dysfunction, Prostate Cancer), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

男性健康診斷市場2023年估值為131.7億美元，預計到2024年將達到145.9億美元，複合年成長率為11.31%，到2030年將達到278.9億美元。

男性健康診斷市場包括各種診斷工具和服務，旨在識別、監測和管理男性族群中常見的常見健康問題，例如心血管疾病、攝護腺癌、低睪固酮和糖尿病。這些診斷解決方案包括先進的影像技術、生物標記測試、基因篩檢、實驗室測試、照護現場診斷等。隨著人們對男性健康問題的認知不斷提高，這些診斷對於預防醫學和精確治療方法至關重要。它們的應用範圍涵蓋醫院、診斷中心、診所和家庭，對於實現定期監測和早期檢測、改善患者治療效果至關重要。這個市場主要由男性特有疾病的增加、健康意識的提高、技術進步和創新的診斷方法所推動。最近的趨勢包括人工智慧和診斷工具的整合以提高診斷準確性、開發非侵入性測試方法以及滿足個人需求的個人化醫療解決方案。此外，在數位醫療採用增加的推動下，遠端醫療和遠距離診斷代表了大幅成長的途徑。然而，新興市場面臨診斷測試成本上升、意識缺乏以及醫療基礎設施不發達等挑戰，可能會阻礙市場擴張。圍繞診斷測試的嚴格法規和報銷問題也是主要障礙。創新機會在於開發具有成本效益的診斷解決方案，提高測試方法的準確性和可近性，以及促進高科技公司和醫療保健提供者之間的夥伴關係。調查可能會集中在發現生物標記、基於人工智慧的診斷和加強遠端醫療技術上。男性健康診斷市場正在動態發展，重點是精準醫療和早期檢測，這推動了對促進男性健康整體方法的技術和服務的策略性投資的需求。專注於可及性、效率和個人化護理的公司將在這個不斷變化的市場環境中獲得豐厚的回報。

主要市場統計
基準年[2023] 131.7億美元
預測年份 [2024] 145.9億美元
預測年份 [2030] 278.9億美元
複合年成長率（%） 11.31%

市場動態：快速發展的男性健康診斷市場的關鍵市場洞察

供需的動態交互作用正在改變男性健康診斷市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 不健康的飲食習慣和吸煙人數的增加
    • 與文明病增加
    • 全球診斷中心數量增加
  • 市場限制因素
    • 醫療服務分佈不均衡
    • 有限的保險範圍和監管合規性
  • 市場機會
    • 政府積極努力加強醫療體系
    • 將物聯網和人工智慧等創新技術整合到診斷中
  • 市場挑戰
    • 缺乏技術精湛、經驗豐富的人才

波特五力：駕馭男性健康診斷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解男性健康診斷市場的外部影響

外部宏觀環境因素在塑造男性健康診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解男性健康診斷市場的競爭狀況

對男性健康診斷市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣供應商在男性健康診斷市場的績效評估

FPNV 定位矩陣是評估男性健康診斷市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了男性健康診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對男性健康診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 不健康的飲食習慣和吸煙人數的增加
      • 與文明病發生率增加
      • 世界各地診斷中心的數量正在增加
    • 抑制因素
      • 衛生服務分配不均
      • 有限的保險範圍和監管合規性
    • 機會
      • 政府加強醫療保健系統的有利舉措
      • 將物聯網和人工智慧等創新技術整合到診斷中
    • 任務
      • 缺乏熟練且經驗豐富的勞動力
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章男性健康診斷市場：依產品

  • 驗血
  • 心電圖
  • 前列腺 MRI
  • 睪固酮水平測試
  • 超音波檢查
  • 超音波引導前列腺切片檢查
  • 造影檢查
  • 尿液檢查
  • X光

第7章按類型或適應症分類的男性健康診斷市場

  • 大腸直腸癌
  • 勃起功能障礙
  • 攝護腺癌
  • 睪丸癌

第8章男性健康診斷市場：依最終用戶分類

  • 診斷實驗室
  • 醫院及門診手術中心
  • 研究/學術機構

第9章 北美和南美男性健康診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區男性健康診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的男性健康診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Access Pharmaceuticals, Inc.
  • ADVANZ PHARMA Corp Limited
  • Beckman Coulter, Inc.
  • Bruker Corporation
  • Cardinal Health Inc.
  • Ecotown Diagnostics Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Future Diagnostics Solutions BV
  • Medical Diagnosis
  • Neuberg Diagnostics
  • Nuance Communications, Inc.
  • Pathnostics
  • PERSOWN, INC.
  • Quest Diagnostics Incorporated
  • SEKISUI DIAGNOSTICS, LLC
Product Code: MRR-431388EE3BC2

The Mens Health Diagnostics Market was valued at USD 13.17 billion in 2023, expected to reach USD 14.59 billion in 2024, and is projected to grow at a CAGR of 11.31%, to USD 27.89 billion by 2030.

The men's health diagnostics market entails various diagnostic tools and services aimed at identifying, monitoring, and managing common health issues prevalent among male populations, such as cardiovascular diseases, prostate cancer, low testosterone, diabetes, and other conditions. These diagnostic solutions encompass advanced imaging techniques, biomarker tests, genetic screening, lab tests, and point-of-care diagnostics. As awareness of men's health issues grows, these diagnostics are essential for preventive health care and accurate treatment approaches. Their application spans hospitals, diagnostic centers, clinics, and home settings, enabling regular monitoring and early detection, which are crucial for improving patient outcomes. The market is predominantly driven by increasing incidences of male-specific diseases, rising health consciousness, advancements in technology, and innovative diagnostic methods. Recent opportunities rest in integrating AI with diagnostic tools for enhanced accuracy, the development of non-invasive testing methods, and personalized healthcare solutions to cater to individual needs. Additionally, telemedicine and remote diagnostics present substantial growth avenues, driven by increased digital health adoption. However, the market faces challenges, including high costs of diagnostic tests, lack of awareness, and inadequate healthcare infrastructure in developing regions, which might hinder market expansion. Stringent regulations related to diagnostic tests and reimbursement issues also pose significant obstacles. Innovation opportunities lie in developing cost-effective diagnostic solutions, improving the accuracy and accessibility of testing methods, and fostering partnerships between tech companies and healthcare providers. Research could focus on biomarker discovery, AI-driven diagnostics, and enhancing telehealth technologies. The men's health diagnostics market is dynamic and evolving, with an emphasis on precision medicine and early detection, emphasizing the need for strategic investments in technology and services that promote a holistic approach to men's health. Companies focusing on accessibility, efficiency, and personalized care stand to reap significant rewards in this evolving market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 13.17 billion
Estimated Year [2024] USD 14.59 billion
Forecast Year [2030] USD 27.89 billion
CAGR (%) 11.31%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mens Health Diagnostics Market

The Mens Health Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Unhealthy eating habits and growing prevalence of smoking population
    • Increased incidence of lifestyle disease
    • Rise in number of diagnostic centers all over the globe
  • Market Restraints
    • Uneven distribution of medical services
    • Limited insurance coverage and regulatory compliance
  • Market Opportunities
    • Favorable government initiatives to strengthen healthcare system
    • Integration of innovative technologies such as IoT and AI in diagnostic
  • Market Challenges
    • Shortage of skilled and experienced workforce

Porter's Five Forces: A Strategic Tool for Navigating the Mens Health Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mens Health Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mens Health Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mens Health Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mens Health Diagnostics Market

A detailed market share analysis in the Mens Health Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mens Health Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mens Health Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mens Health Diagnostics Market

A strategic analysis of the Mens Health Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mens Health Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Access Pharmaceuticals, Inc., ADVANZ PHARMA Corp Limited, Beckman Coulter, Inc., Bruker Corporation, Cardinal Health Inc., Ecotown Diagnostics Pvt. Ltd., F. Hoffmann-La Roche Ltd., Future Diagnostics Solutions B.V., Medical Diagnosis, Neuberg Diagnostics, Nuance Communications, Inc., Pathnostics, PERSOWN, INC., Quest Diagnostics Incorporated, and SEKISUI DIAGNOSTICS, LLC.

Market Segmentation & Coverage

This research report categorizes the Mens Health Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blood Test, Electrocardiogram, MRI of the Prostate, Testosterone Levels Test, Ultrasound Test, Ultrasound-Guided Prostate Biopsy, Urethrogram, Urine Tests, and X-Ray.
  • Based on Type or Indication, market is studied across Colorectal Cancer, Erectile Dysfunction, Prostate Cancer, and Testicular cancer.
  • Based on End-user, market is studied across Diagnostic Laboratories, Hospitals & Ambulatory Surgery Center, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Unhealthy eating habits and growing prevalence of smoking population
      • 5.1.1.2. Increased incidence of lifestyle disease
      • 5.1.1.3. Rise in number of diagnostic centers all over the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Uneven distribution of medical services
      • 5.1.2.2. Limited insurance coverage and regulatory compliance
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives to strengthen healthcare system
      • 5.1.3.2. Integration of innovative technologies such as IoT and AI in diagnostic
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled and experienced workforce
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mens Health Diagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Test
  • 6.3. Electrocardiogram
  • 6.4. MRI of the Prostate
  • 6.5. Testosterone Levels Test
  • 6.6. Ultrasound Test
  • 6.7. Ultrasound-Guided Prostate Biopsy
  • 6.8. Urethrogram
  • 6.9. Urine Tests
  • 6.10. X-Ray

7. Mens Health Diagnostics Market, by Type or Indication

  • 7.1. Introduction
  • 7.2. Colorectal Cancer
  • 7.3. Erectile Dysfunction
  • 7.4. Prostate Cancer
  • 7.5. Testicular cancer

8. Mens Health Diagnostics Market, by End-user

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Hospitals & Ambulatory Surgery Center
  • 8.4. Research & Academic Institutes

9. Americas Mens Health Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Mens Health Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Mens Health Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Access Pharmaceuticals, Inc.
  • 2. ADVANZ PHARMA Corp Limited
  • 3. Beckman Coulter, Inc.
  • 4. Bruker Corporation
  • 5. Cardinal Health Inc.
  • 6. Ecotown Diagnostics Pvt. Ltd.
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Future Diagnostics Solutions B.V.
  • 9. Medical Diagnosis
  • 10. Neuberg Diagnostics
  • 11. Nuance Communications, Inc.
  • 12. Pathnostics
  • 13. PERSOWN, INC.
  • 14. Quest Diagnostics Incorporated
  • 15. SEKISUI DIAGNOSTICS, LLC

LIST OF FIGURES

  • FIGURE 1. MENS HEALTH DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. MENS HEALTH DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MENS HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MENS HEALTH DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MRI OF THE PROSTATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTOSTERONE LEVELS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND-GUIDED PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URETHROGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ERECTILE DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTICULAR CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023